Skip to main content
SpringerLink
Log in

Surgical and Medical Treatment of Secondary Hyperparathyroidism in Patients on Continuous Dialysis

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Secondary hyperparathyroidsm (2HPT) is a common complication in hemodialysis patients associated with morbidity and sometimes mortality. The majority of patients with 2HPT can be managed by medical treatment. However, medical treatment does not always provied control of parathyroid disorder. Some patients require surgical treatment, parathyroidetomy (PTx). Successful surgical treatment often results in dramatic drop of the parathyroid hormone (PTH) levels, relieves the patients from clinical symptoms, and reduces mortality. However, at present we do not have reliable evidences showing that PTx.

Methods

The published papers about medical and surgical treatment for 2HPT within the last 10 years were evaluated to acquire the evidence for the adequate surgical treatments for 2HPT.

Results

Many retrospective, observation studies have confirmed that successful PTx can achieve a dramatic drop of PTH levels, relieve symptoms of 2HPT and reduce mortality. However, we do not have reliable evidence that PTx compared with placebo or active drugs, improves mortality or outcome with respect to cardiovascular symptoms, bone disease, or biochemical parameter. The indications for surgery may be strongly influenced by medical therapy, including treatment with calcimimetics, as well as by composition of the patients material and medical insurance system. There are many treatment of modalities in addition to PTx for dialysis patients with 2HPT. Moreover, we do not have clear evidence telling us which operative procedures is most appropriate for 2HPT, with respect to clinical effectiveness, mortality or risk for recurrence.

Conclusion

To acquire the evidence for the adequate medical and surgical treatment for 2HPT including operative procedures, randomized controlled prospective studies are requires.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis patients. J Am Soc Nephrol 15:2208–2218

    Article  PubMed  CAS  Google Scholar 

  2. Stevens LA, Djurdjev O, Cardew S et al (2004) Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 15:770–779

    Article  PubMed  CAS  Google Scholar 

  3. Block GA, Shearon EH, Levin NW et al (1998) Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607–617

    Article  PubMed  CAS  Google Scholar 

  4. Block GA, Port FK (2000) Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35:1226–1237

    Article  PubMed  CAS  Google Scholar 

  5. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S140

    Google Scholar 

  6. Andia JBC, Drueke TB, Cunningham J et al (2000) Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant 15(Suppl 5):2–57

    Google Scholar 

  7. Guidline Working Group, Japanese Society for Dialysis Therapy (2008) Clinical practice guidline for management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial 12:514–525

    Google Scholar 

  8. Malberti F, Marcelli D, Conte F et al (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 12:1242–1248

    PubMed  CAS  Google Scholar 

  9. Jorna FH, Tobe TJM, Huisman RM et al (2004) Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant 19:1168–1173

    Article  PubMed  Google Scholar 

  10. Goodman WG (2002) Calcimimetic agents and secondary hyperparathyroidism: treatment and prevention. Nephrol Dial Transplant 17:204–207

    Article  PubMed  CAS  Google Scholar 

  11. Young EW, Albert JM, Satayathum S et al (2005) Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study. Kidney Int 67:1179–1187

    Article  PubMed  CAS  Google Scholar 

  12. Maeda K (1997) An overview of dialysis treatment in Japan as of Dec 31. J Jpn Soc Dial Ther 32:1–17; in Japanese

    Google Scholar 

  13. Kestenbaum B, Seliger SL, Gillen DL et al (2004) Parathyroidectomy rates among united states dialysis patients: 1990–1999. Kidney Int 65:282–288

    Article  PubMed  Google Scholar 

  14. Foley RN, Li S, Liu J et al (2005) The fall, rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 16:210–218

    Article  PubMed  Google Scholar 

  15. Cunningham J (2000) Are parathyroidectomies still appropriate in chronic dialysis patients? Semin Dial 13:275–278

    Article  PubMed  CAS  Google Scholar 

  16. Cunningham J, Danese M, Olson K et al (2005) Effect of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and healthy-related quality of life in secondary hyperparathyroidism. Kidney Int 68:1793–1800

    Article  PubMed  CAS  Google Scholar 

  17. Tominaga Y, Matsuoka S, Sato T (2005) Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9:44–47

    Article  PubMed  Google Scholar 

  18. Fukagawa M, Kitaoka M, Yi H et al (1994) Serial evaluation of parathyroid size by ultrasonography is another useful marker for long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68:221–228

    Article  PubMed  CAS  Google Scholar 

  19. Tominaga Y, Inaguma D, Matsuoka S et al (2006) Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? Ther Apher Dial 10:198–204

    Article  PubMed  CAS  Google Scholar 

  20. Tominaga Y, Kohara S, Namii Y et al (1993) Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 20:744–750

    Article  Google Scholar 

  21. Fukuda N, Tanaka H, Tominaga Y et al (1993) Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436–1443

    Article  PubMed  CAS  Google Scholar 

  22. Gogusev J, Duchambon P, Hory B et al (1997) Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328–336

    Article  PubMed  CAS  Google Scholar 

  23. Tominaga Y, Matsuoka S, Sato T et al (2007) Clinical features and hyperplastic pattern of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy. Ther Dial Apher 11:266–273

    Article  Google Scholar 

  24. Tominaga Y, Matsuoka S, Uno N (2008) Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 12(Suppl 1):S21–S26

    Article  PubMed  Google Scholar 

  25. Narayan R, Perkins RM, Berbano EP et al (2007) Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 49:801–813

    Article  PubMed  Google Scholar 

  26. Lomonte C, Antonelli M, Losurdo N et al (2007) Cinacalcet is effective in relapses of secondary hyperparathyroisidm after parathyroidectomy. Nephrol Dial Transplant 22:2056–2062

    Article  PubMed  CAS  Google Scholar 

  27. Silverberg SJ, Rubin MR, Faiman C et al (2007) Cinacalcet hydrochrolide reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92:3803–3808

    Article  PubMed  CAS  Google Scholar 

  28. Eriguchi R, Umakoshi J, Tominaga Y et al (2008) Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl. Neprol Dial Transplant Plus 4:218–220

    Google Scholar 

  29. Rohmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15:745–750

    Article  Google Scholar 

  30. Hampl H, Steinmuller T, Frohling P et al (1999) Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure. Miner Electrolyte Metab 25:161–170

    Article  PubMed  CAS  Google Scholar 

  31. Takagi H, Tominaga Y, Uchida K et al (1984) Subtotal versus total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg 200:18–23

    Article  PubMed  CAS  Google Scholar 

  32. Tominaga Y, Uchida K, Haba T et al (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38(Suppl):S166–S171

    Google Scholar 

  33. Yu I, DeVita MV, Komisar A (1998) Long-term follow-up after subtotal parathyroidectomy in patients with renal failure. Laryngoscope 108:1824–1828

    Article  PubMed  CAS  Google Scholar 

  34. Nicholson ML, Veitch PS, Feehally J (1996) Parathyroidectomy in chronic renal failure: comparison of three operative strategies. J R Coll Surg Edinb 41:382–387

    PubMed  CAS  Google Scholar 

  35. Hargrove GM, Pasieka JL, Hanley DA et al (1999) Short-and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol 19:559–564

    Article  PubMed  CAS  Google Scholar 

  36. Zaraca F, Mazzaferro S, Catarci M et al (1999) Prospective evaluation of total parathyroidectomy and autotransplantation for the treatment of secondary hyperparathyroidism. Arch Surg 134:68–72

    Article  PubMed  CAS  Google Scholar 

  37. Feldman AL, Sharaf RN, Skarulis MC et al (1999) Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery 126:1042–1048

    Article  PubMed  CAS  Google Scholar 

  38. Richards ML, Wormuth J, Bingener J et al (2006) Parathyroidectomy in secondary hyperparathyroidism: is there an optimal operative management? Surgery 139:174–180

    Article  PubMed  Google Scholar 

  39. Tominaga Y, Tanaka Y, Sato K et al (1992) Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16:595–602

    Article  PubMed  CAS  Google Scholar 

  40. Neyer U, Hoerandner H, Haid A et al (2002) Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 17:625–629

    Article  PubMed  Google Scholar 

  41. Wells SA, Gunnells JC, Shelbourne JD et al (1975) Transplantation of parathyroid glands in men: clinical indications and results. Surgery 78:34–44

    PubMed  Google Scholar 

  42. Lieu D, Hirschowitz SL, Skinner KA et al (1998) Recurrent secondary hyperparathyroidism after autotransplantation into the sternocleidomastoid muscle. Acta Cytol 42:1195–1198

    PubMed  CAS  Google Scholar 

  43. Kinnaert P, Salmon I, Decoster-Gervy C et al (2000) Long-term results of subcutaneous parathyroid grafts in uremic patients. Arch Surg 135:186–190

    Article  PubMed  CAS  Google Scholar 

  44. Chou FF, Chan HM, Huang TJ et al (1998) Autotransplantation of parathyroid glands into subcutaneous forearm tissue for renal hyperparathyroidism. Surgery 124:1–5

    PubMed  CAS  Google Scholar 

  45. Elizondo ME, Amondarain JA, Vidaur F et al (2007) Parathyroid subcutaneous pre-sternal transplantation after parathyroidectomy for renal hyperparathyroidism. long-term graft function. World J Surg 31:1403–1409

    Article  Google Scholar 

  46. Lorenz K, Ukkat J, Sekulla C et al (2006) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg 30:743–751

    Article  PubMed  Google Scholar 

  47. Ljutic D, Cameron JS, Ogg CS et al (1994) Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure. Q J Med 87:685–692

    CAS  Google Scholar 

  48. Stracke S, Jehle PM, Sturm D et al (1999) Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis 33:304–311

    Article  PubMed  CAS  Google Scholar 

  49. Schlosser K, Veit JA, Witte S et al (2007) Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial. Trials 8:1–22

    Article  Google Scholar 

  50. Kakuta T, Fukagawa M, Fujisaki T et al (1999) Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 33:1091–1099

    Article  PubMed  CAS  Google Scholar 

  51. Nakamura M, Fuchinoue S, Teraoka S (2003) Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism. Am J Kidney Dis 33:739–745

    Article  Google Scholar 

  52. Fukagawa M, Kitaoka M, Tominaga Y et al (1999) Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients: the Japanese strategy. Nephrol Dial Transplant 14:2574–2577

    Article  PubMed  CAS  Google Scholar 

  53. Koiwa F, Kakuta T, Tanaka R et al (2007) Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant 22:522–528

    Article  PubMed  CAS  Google Scholar 

  54. Nakamura M, Marui Y, Ubara Y et al (2008) Effects of percutaneous ethanol injection therapy on subsequent surgical parathyroidectomy. Nephrol Dial Transplant 1(Suppl 3):iii39–iii41

    Google Scholar 

  55. Tominaga Y (2008) Current status of parathyroidectomy for secondary hyperparathyroidism in Japan. Nephrol Dial Transplant 1(Suppl 3):iii35–iii38

    Google Scholar 

  56. Mazzaferro S, Pasquali M, Farcomeni A et al (2008) Parathyroidectomy as therapeutic tool for targeting the recommended NKF-K/DOQI™ ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 23:2319–2323

    Article  PubMed  CAS  Google Scholar 

  57. Pasieka JL, Parsons LL (2000) A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism. Surgery 128:531–539

    Article  PubMed  CAS  Google Scholar 

  58. Chou FF, Chen JB, Lee CH et al (2001) Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism. Arch Surg 136:1064–1068

    Article  PubMed  CAS  Google Scholar 

  59. Yajima A, Ogawa Y, Takahashi HF et al (2003) Changes of bone remodering immediately after parathyroiddectomy for secondary hyperparathyroidism. Am J Kidney Dis 42:729–738

    Article  PubMed  Google Scholar 

  60. Yajima A, Inaba M, Tominaga Y et al (2008) Bone formation by minimodeling Is more active than remodeling after parathyroidectomy. Kidney Int 74:775–781

    Article  PubMed  Google Scholar 

  61. Rudser KD, Boer IH, Dooley A et al (2007) Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 18:2401–2407

    Article  PubMed  Google Scholar 

  62. Patetsios P, Bernstein M, Kim S et al (2000) Severe necrotizing mastopathy caused by calciphylaxis alleviated by total parathyroidectomy. Am Surg 66:1056–1058

    PubMed  CAS  Google Scholar 

  63. Sabeel A, Homrany MA (2000) Complete resorption of massive soft tissue calcification in a hemodialysis patient after parathyroidectomy. Am J Nephrol 20:421–424

    Article  PubMed  CAS  Google Scholar 

  64. Inoshita H, Gohda T, Lo H et al (2008) Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient. Clin Nephrol 69:58–62

    PubMed  CAS  Google Scholar 

  65. Duffy A, Schurr M, Warner T et al (2006) Long-term outcomes in patients with calciphylaxis from hyperparathyroidism. Ann Surg Oncol 13:96–102

    Article  PubMed  Google Scholar 

  66. Leo CD, Gallieni M, Bestetti A et al (2003) Cardiac and pulmonary calcification in a hemodialysis patient: partial regression 4 years after parathyroidectomy. Clin Nephrol 59:59–63

    PubMed  Google Scholar 

  67. Goto N, Tominaga Y, Matsuoka S et al (2005) Cardiovascular complications caused advanced secondary hyperparathyroidism in chronic dialysis patients; specific focus on dilated cardiomyopathy. Clin Exp Nephrol 9:138–141

    Article  PubMed  Google Scholar 

  68. Diezhandino MG (1996) Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin:effect of parathyroidectomy. Clin Nephrol 45:420–421

    Google Scholar 

  69. Rault R, Magnone M (1996) The effect of parathyroidectomy on hematocrit and erythropoietin dose in patients on hemodialysis. ASAIO J 42:M901–M903

    Article  PubMed  CAS  Google Scholar 

  70. Chou FF, Lee CH, Lee CT (1999) Muscle force and bone mineral density after parathyroidectomy and subcutaneous autotransplantation for secondary hyperparathyroidism. World J Surg 23:452–457

    Article  PubMed  CAS  Google Scholar 

  71. Yasunaga C, Nakamoto M, Matsuo K et al (1999) Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism. Am J Surg 178:332–336

    Article  PubMed  CAS  Google Scholar 

  72. Khajehdehi P, Ali M, Gebory FA et al (1999) The effects of parathyroidectomy on nutritional and biochemical status of hemodialysis patients with severe secondary hyperparathyroidism. J Renal Nutr 9:186–191

    Article  CAS  Google Scholar 

  73. Martins CT, Futata E, Jorgetti V et al (2000) Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 84:224–227

    Article  Google Scholar 

  74. Chou FF, Chen JB, Hsieh KC et al (2008) Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism. Surgery 143:526–532

    Article  PubMed  Google Scholar 

  75. Goldsmith DJA, Covic AA, Venning MC et al (1996) Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. Am J Kidney Dis 27:819–825

    Article  PubMed  CAS  Google Scholar 

  76. Pizzarelli F, Fabrizi F, Postorino M et al (1993) Parathyroidectomy and blood pressure in hemodialysis patients. Nephron 63:384–389

    Article  PubMed  CAS  Google Scholar 

  77. Kestenbaum B, Andress DL, Schwartz SM et al (2004) Survival following parathyroidectomy among United States dialysis patients. Kidney Int 66:2010–2016

    Article  PubMed  Google Scholar 

  78. Trombetti A, Stoermann C, Robert JH et al (2007) Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism. World J Surg 31:1014–1021

    Article  PubMed  Google Scholar 

  79. Dussol B, Morand P, Martinat C et al (2007) Influence of parathyroidectomy on mortality in hemodialysis patients: a prospective observational study. Ren Fail 29:579–586

    Article  PubMed  CAS  Google Scholar 

  80. Costa-Hong V, Jorgetti V, Gowdak LHW et al (2007) Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 142:699–703

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Transplant and Endocrine Surgery, Nagoya Second Red Cross Hospital, 2-9, Myoken-cho Showa-ku, Nagoya, 4668650, Japan

    Yoshihiro Tominaga, Susumu Matsuoka & Nobuaki Uno

Authors
  1. Yoshihiro Tominaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susumu Matsuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobuaki Uno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshihiro Tominaga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tominaga, Y., Matsuoka, S. & Uno, N. Surgical and Medical Treatment of Secondary Hyperparathyroidism in Patients on Continuous Dialysis. World J Surg 33, 2335–2342 (2009). https://doi.org/10.1007/s00268-009-9943-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-009-9943-3

Keywords

Search

Navigation